Ibrance 100 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26F6X8J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,560
Award facts
- Contract value 100% obligated
- $8,559.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,559.84 to Amerisourcebergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 13, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is part of the company's broader engagement with the Defense Logistics Agency Medical Supply Chain, which encompasses the delivery of a comprehensive range of pharmaceutical products.
This delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency valued up to $999,999,999.00 through December 31, 2031. This IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The competitive award demonstrates the contractor's capability to fulfill federal procurement requirements for essential pharmaceutical supplies required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F6X8J?
SPE2DR26F6X8J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F6X8J worth?
The government has obligated $8,560 on SPE2DR26F6X8J.
Is contract SPE2DR26F6X8J an order under another contract?
Yes. SPE2DR26F6X8J is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X8J competed?
The extent of competition for SPE2DR26F6X8J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award